Table 1 Association between HSPA13 expression and clinicopathologic characteristics in HCC.
From: Heat shock protein HSPA13 promotes hepatocellular carcinoma progression by stabilizing TANK
Clinicopathological characteristics | HSPA13 Expression | p | |
|---|---|---|---|
High | Low | ||
Age | |||
 ≥60 | 22 | 4 | 0.45 |
 <60 | 30 | 9 | |
Gender | |||
 Female | 12 | 1 | 0.44 |
 Male | 40 | 12 | |
Tumor size | |||
 ≤5 cm | 12 | 4 | 0.72 |
 >5 cm | 40 | 9 | |
Differentiation level | |||
 High/Middle | 45 | 13 | 0.33 |
 Low | 7 | 0 | |
AFP (ug/L)a | |||
 <200 | 30 | 9 | 0.54 |
 ≥200 | 21 | 4 | |
Vascular invasion | |||
 Without | 20 | 10 | 0.03* |
 With | 32 | 3 | |
HBV DNAb | |||
 <1000 | 13 | 4 | 0.08 |
 ≥1000 | 22 | 9 | |
Satellite foci | |||
 Without | 38 | 9 | 0.74 |
 With | 14 | 4 | |
Liver cirrhosisc | |||
 Without | 9 | 1 | 0.67 |
 With | 40 | 11 | |
